| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016636270 |
| P356 | DOI | 10.1186/CC8010 |
| P932 | PMC publication ID | 2786114 |
| P698 | PubMed publication ID | 19951384 |
| P5875 | ResearchGate publication ID | 51440253 |
| P50 | author | Can Ince | Q92757506 |
| P2093 | author name string | Paolo Pelaia | |
| Rick Bezemer | |||
| Laura Botticelli | |||
| Abele Donati | |||
| Vincenzo Gabbanelli | |||
| Agnese Valentini | |||
| Michela Romanelli | |||
| Simonetta Nataloni | |||
| Tiziana Principi | |||
| P2860 | cites work | The microcirculation is the motor of sepsis | Q24633735 |
| Efficacy and safety of recombinant human activated protein C for severe sepsis | Q29547839 | ||
| Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis | Q30493116 | ||
| Regional microvascular function and vascular reactivity in patients with different degrees of multiple organ dysfunction syndrome. | Q33237218 | ||
| The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock | Q33433376 | ||
| Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock | Q34314380 | ||
| Monitoring tissue oxygen availability with near infrared spectroscopy (NIRS) in health and disease. | Q34321275 | ||
| 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. | Q35094247 | ||
| New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). | Q36259602 | ||
| Near infrared spectroscopy for evaluation of the trauma patient: a technology review | Q36329886 | ||
| Impairments in microvascular reactivity are related to organ failure in human sepsis | Q40215829 | ||
| Activated protein C, a natural anticoagulant protein, has antioxidant properties and inhibits lipid peroxidation and advanced glycation end products formation. | Q40466365 | ||
| Activated protein C prevents endotoxin-induced hypotension in rats by inhibiting excessive production of nitric oxide | Q43727878 | ||
| Microvascular blood flow is altered in patients with sepsis | Q44045816 | ||
| Microvascular dysfunction and skeletal muscle oxygenation assessed by phase-modulation near-infrared spectroscopy in patients with septic shock | Q45283334 | ||
| Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress | Q46643306 | ||
| Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia | Q47797708 | ||
| Activated protein C reduces tissue hypoxia, inflammation, and apoptosis in traumatized skeletal muscle during endotoxemia. | Q54439750 | ||
| DYNAMIC NEAR-INFRARED SPECTROSCOPY MEASUREMENTS IN PATIENTS WITH SEVERE SEPSIS | Q61651190 | ||
| The prognostic value of muscle StO2 in septic patients | Q64126793 | ||
| Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis | Q64126881 | ||
| Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment* | Q64126934 | ||
| Microvascular function and rheologic changes in hyperdynamic sepsis | Q72571917 | ||
| Nitroglycerin in septic shock after intravascular volume resuscitation | Q78494402 | ||
| Changes in muscle tissue oxygenation during stagnant ischemia in septic patients | Q81425041 | ||
| P921 | main subject | infrared spectroscopy | Q70906 |
| sepsis | Q183134 | ||
| drotrecogin alfa | Q412888 | ||
| P304 | page(s) | S12 | |
| P577 | publication date | 2009-11-30 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Recombinant activated protein C treatment improves tissue perfusion and oxygenation in septic patients measured by near-infrared spectroscopy | |
| P478 | volume | 13 Suppl 5 |
| Q53271048 | Comparison of two devices using near-infrared spectroscopy for the measurement of tissue oxygenation during a vascular occlusion test in healthy volunteers (INVOS® vs. InSpectra™). |
| Q42258423 | From macrohemodynamic to the microcirculation |
| Q37929901 | Microcirculatory alterations: potential mechanisms and implications for therapy |
| Q26798312 | Microcirculatory dysfunction and resuscitation: why, when, and how |
| Q37356648 | Near-infrared spectroscopy StO2 monitoring to assess the therapeutic effect of drotrecogin alfa (activated) on microcirculation in patients with severe sepsis or septic shock |
| Q37302256 | Near-infrared spectroscopy for assessing tissue oxygenation and microvascular reactivity in critically ill patients: a prospective observational study |
| Q26851227 | Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock |
| Q35560929 | Plasma free hemoglobin and microcirculatory response to fresh or old blood transfusions in sepsis |
| Q34114355 | Protein targets of inflammatory serine proteases and cardiovascular disease |
| Q34999953 | The aPC treatment improves microcirculation in severe sepsis/septic shock syndrome |
| Q33629515 | Tissue saturation measurement--exciting prospects, but standardisation and reference data still needed |
| Q37966024 | Year in review 2010: Critical Care--Cardiology |
Search more.